Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neuroprotective Effect of Desflurane in Rat Ischemia Model
NCT04287842Phase 4Withdrawn
- Sponsor
- Negovsky Research Institute of General Reanimatology
- Start
- May 2015
- Primary completion
- May 2015
- Modality
- Allosteric Modulators
01
Overview
Phase 4, randomised trial of desflurane in ischemic brain injury (4 arms), sponsored by Negovsky Research Institute of General Reanimatology. Primary endpoint: Total GSK-3b and Phosphorylated (pGSK-3b) Content. Planned start May 2015; status: withdrawn.
02
Drugs
desflurane
03
Conditions
ischemic brain injury
Beyond the preview
Go deeper on NCT04287842.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04287842.